NEURO2024

Presentation information

Print

Training School for Next Generation Scientists

[3TS11m] MC and BC, Disease 1

Fri. Jul 26, 2024 8:45 AM - 10:45 AM Room 11 (409)

Senior Discussant: Hiroshi Nomura (Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences), Kenji Mizuseki (Osaka Metropolitan University Graduate School of Medicine)
Young Chair: Minobu Ikehara (Department of psychiatry, Nara Medical University)

[3TS11m-01] Development of AAV vectors with enhanced cell-type specificity and labeling efficiency by optimizing genetic regulatory elements

*Leo Kojima1, Kaoru Seiriki1, Hiroki Rokujo1, Takanobu Nakazawa2, Atsushi Kasai1,3, Hitoshi Hashimoto1,4,5,6,7 (1. Lab. Mol. Neuropharmacol., Grad. Sch. Pharmaceut. Sci., Osaka Univ., Osaka, 2. Dept. Biosci., Fac. Life Sci., Tokyo Univ. Agr., Tokyo, Japan, 3. Drug Innovation Center, Grad. Sch. of Pharmaceut. Sci., Osaka Univ., Osaka, Japan, 4. Mol. Res. Ctr. Child. Ment. Dev., United Grad. Sch. Child Dev., Osaka Univ., Osaka, Japan, 5. Inst. Datability Sci., Osaka Univ., Osaka, Japan, 6. Inst. for Open Transdisciplinary Res. Initiatives, Osaka Univ., Osaka, Japan, 7. Dept. of Mol. Pharmaceut. Sci., Grad. Sch. of Med., Osaka Univ., Osaka, Japan)

Keywords:AAV

Please log in with your participant account.
» Participant Log In